Join Today

PMC members shape and advance the future of personalized medicine.
» Sign Up Today


PMC Hill Briefing Spotlights Personalized Medicine

PMC's briefing on Capitol Hill last week shined the political spotlight on personalized medicine, emphasizing the importance of appropriating funding for the National Institutes of Health (NIH) to implement President Obama's Precision Medicine Initiative (PMI) in front of a standing-room only crowd of more than 125 that included more than 50 Hill staffers.
» Education & Advocacy

NIH Requesting Feedback on M-Health, PMI
The National Institutes of Health (NIH) are requesting feedback on incorporating mobile technologies into the Precision Medicine Initiative (PMI). The request solicits information on five specific "m-health" topics.

'Cures' Regulation Provisions Under Fire
A recent New York Times editorial characterizes the legislation as containing "flawed" provisions that would allow a drug to be tested on humans based on "only limited evidence that it is safe and effective."
» The New York Times

Member News

NPC Study Offers Framework for Assessing Value of CDTs

A new study funded by the National Pharmaceutical Council (NPC) provides a value assessment tool for the evaluation of companion diagnostic tests (CDTs). The tool was developed using information from a literature review and interviews with payers. 
» Education & Advocacy

Vermillion Public Offering Brings in $17.5M
Vermillion has announced the closing of its public stock offering, which raised more than $17.5 million. The company offered 9,602,500 shares of stock at $1.96 per share. Its stock was up 3 percent after closing.
» Vermillion press release

Pfizer Launches Precision Medicine Center
With FDA considering its options for oversight of next-generation sequencing (NGS), Pfizer is using its new Center of Excellence in Precision Medicine (CEPM) to prepare for their increasing prevalence.
» GenomeWeb (subscription content)